Brainstorm Cell Therapeutics Inc (BCLI) — Financial Flexibility Index
Brainstorm Cell Therapeutics Inc (BCLI) has a Financial Flexibility Index of -0.11x as of March 2026. Free cash flow of $-1.32 Million (operating CF $-1.32 Million minus capex $0.00) represents 0% of total liabilities ($11.76 Million). Check Brainstorm Cell Therapeutics Inc PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Brainstorm Cell Therapeutics Inc Financial Flexibility Index (2001–2025)
Historical Financial Flexibility Index trend for Brainstorm Cell Therapeutics Inc across 25 annual periods. See BCLI working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Brainstorm Cell Therapeutics Inc (2001–2025)
Year-by-year free cash flow to debt coverage for Brainstorm Cell Therapeutics Inc. For the full company profile including market capitalisation, see BCLI stock market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.63x | $-6.97 Million | $-6.97 Million | $11.01 Million | ▲ +33.1% |
| 2024 | -0.95x | $-9.09 Million | $-9.09 Million | $9.60 Million | ▲ +58.0% |
| 2023 | -2.25x | $-20.44 Million | $-20.46 Million | $9.07 Million | ▼ -34.0% |
| 2022 | -1.68x | $-19.29 Million | $-19.32 Million | $11.47 Million | ▲ +35.5% |
| 2021 | -2.61x | $-25.93 Million | $-26.27 Million | $9.94 Million | ▼ -18.4% |
| 2020 | -2.20x | $-34.81 Million | $-35.19 Million | $15.79 Million | ▼ -283.7% |
| 2019 | -0.57x | $-10.77 Million | $-11.25 Million | $18.76 Million | ▲ +70.3% |
| 2018 | -1.93x | $-12.02 Million | $-12.39 Million | $6.21 Million | ▼ -391.1% |
| 2017 | -0.39x | $-2.18 Million | $-2.36 Million | $5.54 Million | ▲ +94.1% |
| 2016 | -6.66x | $-5.75 Million | $-5.86 Million | $864.00K | ▼ -167.1% |
| 2015 | -2.49x | $-7.36 Million | $-7.41 Million | $2.95 Million | ▼ -86.6% |
| 2014 | -1.34x | $-4.33 Million | $-4.49 Million | $3.24 Million | ▲ +32.7% |
| 2013 | -1.99x | $-3.95 Million | $-4.05 Million | $1.99 Million | ▲ +18.8% |
| 2012 | -2.44x | $-2.83 Million | $-2.92 Million | $1.16 Million | ▼ -41.2% |
| 2011 | -1.73x | $-2.17 Million | $-2.22 Million | $1.26 Million | ▼ -29.9% |
| 2010 | -1.33x | $-2.06 Million | $-2.07 Million | $1.55 Million | ▼ -348.0% |
| 2009 | -0.30x | $-744.00K | $-744.00K | $2.50 Million | ▲ +44.4% |
| 2008 | -0.54x | $-1.58 Million | $-1.73 Million | $2.95 Million | ▼ -31.7% |
| 2007 | -0.41x | $-1.43 Million | $-1.77 Million | $3.51 Million | ▼ -44.5% |
| 2006 | -0.28x | $-714.00K | $-855.00K | $2.54 Million | ▼ -136.6% |
| 2005 | -0.12x | $-1.04 Million | $-1.25 Million | $8.77 Million | ▲ +95.4% |
| 2004 | -2.57x | $-449.28K | $-677.84K | $174.95K | ▼ -693.0% |
| 2003 | -0.32x | $-15.44K | $-15.44K | $47.67K | ▼ -16.0% |
| 2002 | -0.28x | $-7.01K | $-7.01K | $25.13K | ▲ +56.9% |
| 2001 | -0.65x | $-7.44K | $-7.44K | $11.49K | — |